Takes their 06 order book comfortably over $20m...already a substantial improvement on last year.
A quick look over the last 12 months shows there has been a virtual procession of such contracts, yet in this time the share price has fallen dramatically.
Huntley's issued a buy recommendation back in February when they were trading over 25c...since then the shares have fallen to 13c, in spite no new issues of shares.
It appears the reason for the fall has been a less than expected performance for the 05 year and the apparent off-loading from a substantial shareholder...he still owns a few, but appears to have stopped selling for now.
It appears management are making a genuine attempt to turn things around however, highlighted perhaps by the recent appointment of the new MD and CEO.
I have a very good feeling about this one...and with only 77m shares on issue, it wouldn't take much to shift the balance.
Smells a little like a another TOX scenario unfolding if you ask me...perhaps an opportunity for the patient?
Cheers!
EGL Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)